001     284615
005     20240229155053.0
024 7 _ |a 10.1038/s41590-023-01636-5
|2 doi
024 7 _ |a pmid:37813964
|2 pmid
024 7 _ |a 1529-2908
|2 ISSN
024 7 _ |a 1529-2916
|2 ISSN
024 7 _ |a altmetric:155263120
|2 altmetric
037 _ _ |a DKFZ-2023-02034
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Weisshaar, Nina
|0 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0
|b 0
|e First author
245 _ _ |a The malate shuttle detoxifies ammonia in exhausted T cells by producing 2-ketoglutarate.
260 _ _ |a London
|c 2023
|b Springer Nature Limited
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1700485108_7064
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Nov;24(11):1921-1932 / #EA:D192#LA:D192# / HI-TRON
520 _ _ |a The malate shuttle is traditionally understood to maintain NAD+/NADH balance between the cytosol and mitochondria. Whether the malate shuttle has additional functions is unclear. Here we show that chronic viral infections induce CD8+ T cell expression of GOT1, a central enzyme in the malate shuttle. Got1 deficiency decreased the NAD+/NADH ratio and limited antiviral CD8+ T cell responses to chronic infection; however, increasing the NAD+/NADH ratio did not restore T cell responses. Got1 deficiency reduced the production of the ammonia scavenger 2-ketoglutarate (2-KG) from glutaminolysis and led to a toxic accumulation of ammonia in CD8+ T cells. Supplementation with 2-KG assimilated and detoxified ammonia in Got1-deficient T cells and restored antiviral responses. These data indicate that the major function of the malate shuttle in CD8+ T cells is not to maintain the NAD+/NADH balance but rather to detoxify ammonia and enable sustainable ammonia-neutral glutamine catabolism in CD8+ T cells during chronic infection.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Ma, Sicong
|b 1
700 1 _ |a Ming, Yanan
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Madi, Alaa Abdelghani Mohamed
|0 P:(DE-He78)f05eabc961bc296c088b3510d6429d02
|b 3
|u dkfz
700 1 _ |a Mieg, Alessa
|0 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d
|b 4
|u dkfz
700 1 _ |a Hering, Marvin
|0 P:(DE-He78)b099c4255c1bff642f4d338ef157596e
|b 5
|u dkfz
700 1 _ |a Zettl, Ferdinand
|0 P:(DE-He78)a97252706aa90b10eb9e489f0018ba96
|b 6
|u dkfz
700 1 _ |a Mohr, Kerstin
|0 P:(DE-He78)6c644df06759d9295db52a00eac44c0f
|b 7
|u dkfz
700 1 _ |a ten Bosch, Nora
|0 P:(DE-He78)ad4b5f19b891aeb51245ce42ff3d92ff
|b 8
|u dkfz
700 1 _ |a Stichling, Diana
|0 P:(DE-He78)de81d854a499aca413da2a07204b2dfe
|b 9
|u dkfz
700 1 _ |a Buettner, Michael
|b 10
700 1 _ |a Poschet, Gernot
|b 11
700 1 _ |a Klinke, Glynis
|b 12
700 1 _ |a Schulz, Michael
|b 13
700 1 _ |a Kunze-Rohrbach, Nina
|b 14
700 1 _ |a Kerber, Carolin
|b 15
700 1 _ |a Klein, Isabel Madeleine
|b 16
700 1 _ |a Wu, Jingxia
|b 17
700 1 _ |a Wang, Xi
|b 18
700 1 _ |a Cui, Guoliang
|0 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b
|b 19
|e Last author
|u dkfz
773 _ _ |a 10.1038/s41590-023-01636-5
|0 PERI:(DE-600)2026412-4
|n 11
|p 1921-1932
|t Nature immunology
|v 24
|y 2023
|x 1529-2908
909 C O |p VDB
|o oai:inrepo02.dkfz.de:284615
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)f05eabc961bc296c088b3510d6429d02
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)b099c4255c1bff642f4d338ef157596e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)a97252706aa90b10eb9e489f0018ba96
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)6c644df06759d9295db52a00eac44c0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)ad4b5f19b891aeb51245ce42ff3d92ff
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)de81d854a499aca413da2a07204b2dfe
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2023
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-28
|w ger
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2023-08-28
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT IMMUNOL : 2022
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-28
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-28
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT IMMUNOL : 2022
|d 2023-08-28
920 2 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
920 1 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
920 0 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D192-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21